HomeCompareSTSA vs DIVO

STSA vs DIVO: Dividend Comparison 2026

STSA yields 136.36% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 STSA wins by $15.53M in total portfolio value
10 years
STSA
STSA
● Live price
136.36%
Share price
$1.10
Annual div
$1.50
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15.56M
Annual income
$6,371,447.45
Full STSA calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — STSA vs DIVO

📍 STSA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTSADIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STSA + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
STSA pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STSA
Annual income on $10K today (after 15% tax)
$11,590.91/yr
After 10yr DRIP, annual income (after tax)
$5,415,730.33/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, STSA beats the other by $5,414,873.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STSA + DIVO for your $10,000?

STSA: 50%DIVO: 50%
100% DIVO50/50100% STSA
Portfolio after 10yr
$7.80M
Annual income
$3,186,227.96/yr
Blended yield
40.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STSA right now

STSA
Analyst Ratings
4
Buy
9
Hold
Consensus: Hold
Altman Z
-7.4
Piotroski
2/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STSA buys
0
DIVO buys
0
No recent congressional trades found for STSA or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTSADIVO
Forward yield136.36%6.62%
Annual dividend / share$1.50$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$15.56M$31.0K
Annual income after 10y$6,371,447.45$1,008.47
Total dividends collected$14.30M$8.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: STSA vs DIVO ($10,000, DRIP)

YearSTSA PortfolioSTSA Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$24,336$13,636.36$11,362$661.96+$13.0KSTSA
2$57,055$31,014.91$12,860$702.91+$44.2KSTSA
3$129,004$67,955.30$14,504$743.56+$114.5KSTSA
4$281,633$143,598.62$16,303$783.73+$265.3KSTSA
5$594,333$292,985.93$18,268$823.31+$576.1KSTSA
6$1,213,779$577,842.64$20,408$862.17+$1.19MSTSA
7$2,401,642$1,102,898.48$22,737$900.20+$2.38MSTSA
8$4,609,241$2,039,484.49$25,266$937.31+$4.58MSTSA
9$8,590,007$3,658,118.87$28,008$973.42+$8.56MSTSA
10$15,562,755$6,371,447.45$30,977$1,008.47+$15.53MSTSA

STSA vs DIVO: Complete Analysis 2026

STSAStock

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Full STSA Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this STSA vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STSA vs SCHDSTSA vs JEPISTSA vs OSTSA vs KOSTSA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.